Pfizer Limited (NSE:PFIZER)
India
· Delayed Price · Currency is INR 4,364.00
+40.00 (0.93%)
May 14, 2025, 12:31 PM IST
Pfizer Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 21,932 | 24,248 | 26,110 | 22,386 | 21,517 | Upgrade
|
| Other Revenue | - | - | - | 18.2 | - | Upgrade
|
| Revenue | 21,932 | 24,248 | 26,110 | 22,404 | 21,517 | Upgrade
|
| Revenue Growth (YoY) | -9.55% | -7.13% | 16.54% | 4.12% | 3.37% | Upgrade
|
| Cost of Revenue | 7,983 | 8,778 | 9,529 | 8,028 | 7,984 | Upgrade
|
| Gross Profit | 13,949 | 15,469 | 16,581 | 14,376 | 13,532 | Upgrade
|
| Selling, General & Admin | 4,337 | 3,935 | 4,784 | 4,266 | 4,531 | Upgrade
|
| Other Operating Expenses | 3,219 | 3,434 | 3,425 | 2,971 | 3,159 | Upgrade
|
| Operating Expenses | 8,179 | 8,423 | 9,359 | 8,330 | 8,720 | Upgrade
|
| Operating Income | 5,770 | 7,046 | 7,222 | 6,045 | 4,813 | Upgrade
|
| Interest Expense | -154.1 | -133.9 | -104.9 | -151.1 | -108.5 | Upgrade
|
| Interest & Investment Income | 1,716 | 854.9 | 489.4 | 369.2 | 1,295 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.5 | -12.4 | -15 | 5.1 | -44.5 | Upgrade
|
| Other Non Operating Income (Expenses) | 83.4 | 72.7 | 76.3 | 73.1 | 3.7 | Upgrade
|
| EBT Excluding Unusual Items | 7,406 | 7,827 | 7,668 | 6,342 | 5,959 | Upgrade
|
| Merger & Restructuring Charges | - | -1,363 | - | 243.6 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -30.5 | 0.5 | 45.8 | 33.3 | 294.2 | Upgrade
|
| Other Unusual Items | 79.7 | 1,739 | 12.3 | 57 | 130.2 | Upgrade
|
| Pretax Income | 7,461 | 8,240 | 7,729 | 6,687 | 6,425 | Upgrade
|
| Income Tax Expense | 1,947 | 2,001 | 1,603 | 1,711 | 1,334 | Upgrade
|
| Net Income | 5,513 | 6,239 | 6,126 | 4,976 | 5,091 | Upgrade
|
| Net Income to Common | 5,513 | 6,239 | 6,126 | 4,976 | 5,091 | Upgrade
|
| Net Income Growth | -11.64% | 1.86% | 23.10% | -2.26% | 18.66% | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | Upgrade
|
| EPS (Basic) | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | Upgrade
|
| EPS (Diluted) | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | Upgrade
|
| EPS Growth | -11.64% | 1.86% | 23.10% | -2.26% | 18.66% | Upgrade
|
| Free Cash Flow | 2,379 | 2,907 | 6,518 | 4,096 | 2,848 | Upgrade
|
| Free Cash Flow Per Share | 52.00 | 63.54 | 142.46 | 89.54 | 62.25 | Upgrade
|
| Dividend Per Share | 35.000 | 35.000 | 35.000 | 30.000 | 10.000 | Upgrade
|
| Dividend Growth | - | - | 16.67% | 200.00% | -55.56% | Upgrade
|
| Gross Margin | 63.60% | 63.80% | 63.51% | 64.17% | 62.89% | Upgrade
|
| Operating Margin | 26.31% | 29.06% | 27.66% | 26.98% | 22.37% | Upgrade
|
| Profit Margin | 25.14% | 25.73% | 23.46% | 22.21% | 23.66% | Upgrade
|
| Free Cash Flow Margin | 10.85% | 11.99% | 24.96% | 18.28% | 13.24% | Upgrade
|
| EBITDA | 5,985 | 7,704 | 7,879 | 6,697 | 5,457 | Upgrade
|
| EBITDA Margin | 27.29% | 31.77% | 30.18% | 29.89% | 25.36% | Upgrade
|
| D&A For EBITDA | 215.1 | 658.5 | 656.8 | 652.1 | 644.6 | Upgrade
|
| EBIT | 5,770 | 7,046 | 7,222 | 6,045 | 4,813 | Upgrade
|
| EBIT Margin | 26.31% | 29.06% | 27.66% | 26.98% | 22.37% | Upgrade
|
| Effective Tax Rate | 26.10% | 24.28% | 20.74% | 25.59% | 20.76% | Upgrade
|
| Revenue as Reported | 23,737 | 25,258 | 26,736 | 23,197 | 23,357 | Upgrade
|
| Advertising Expenses | 855.9 | 615.9 | 743.8 | 650.2 | 849.4 | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.